Phase II trial of bevacizumab, cisplatin, and pemetrexed in Japanese patients with advanced nonsquamous non-small cell lung cancer.
Noriko Yanagitani
No relevant relationships to disclose
Fumiyoshi Ohyanagi
No relevant relationships to disclose
Hironari Nishizawa
No relevant relationships to disclose
Hiroshi Gyotoku
No relevant relationships to disclose
Takeshi Uenami
No relevant relationships to disclose
Hiroshi Kobayashi
No relevant relationships to disclose
Keita Kudo
No relevant relationships to disclose
Yuichi Tambo
No relevant relationships to disclose
Atsushi Horiike
No relevant relationships to disclose
Sachiko Hagiwara
No relevant relationships to disclose
Takeshi Horai
No relevant relationships to disclose
Makoto Nishio
Honoraria - Chugai Pharma; Lilly